This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Magellan’s Medication-Assisted Treatment Program Demonstrates Significant Drop In Substance Abuse Readmissions

Today, Magellan Health Services Inc (NASDAQ: MGLN) announced the results of an innovative substance abuse treatment program launched in 2010 called Magellan Integrated Substance Use Solutions . An analysis of a year’s worth of data from the medication-assisted treatment (MAT) portion of that program shows significant reductions in readmissions from participants. Those participating in MAT had 21 percent fewer readmissions to a facility at seven days after discharge than those who were not discharged on medications, 20 percent fewer readmissions after 30 days, and 19 percent fewer readmissions after 60 days.

The same 2011 report indicated that Magellan members with substance abuse diagnoses who participate in a more intensely monitored group due to the severity of their need, had 54 percent fewer readmissions at seven days after discharge than those who were not discharged on medications, 42 percent fewer after 30 days, and 14 percent fewer after 60 days.

“Individuals suffering from substance use disorders and addiction need more than a one-size-fits-all treatment philosophy to ensure they maintain their progress toward recovery and resiliency,” said Gary M. Henschen, M.D., chief medical officer of Magellan Behavioral Health. ”We’ve developed an innovative, comprehensive program that is customizable to the needs of the member, and we can point to the results that show this approach is working.”

Magellan’s Integrated Substance Use Solutions program focuses on clinical interventions, increased provider and member outreach, social networking tools and the use of the most effective pharmacological solutions available in the treatment of substance use disorders. Where clinically appropriate, MAT includes the use of medications such as acamprosate, naltrexone, disulfiram, and buprenorphine that reduce cravings to assist in recovery. As part of the overall program, Magellan monitors the number of cases in which physicians are prescribing medications and measures member readmission rates.

Magellan continually heightens outreach efforts and collaboration with health plans, employer groups and state governments to help facilitate the incorporation of these medications into client formularies. Additionally, Magellan offers supporting resources outlining the effectiveness of using appropriate medications when developing members’ substance use disorder treatment plans.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs